Three years into treatment for stage IV neuroblastoma, Eli was out of options. His cancer was not quitting; but neither was Eli.
His family and local team of doctors in Arkansas found out about some promising treatments available 1,200 miles away in Philadelphia. There was no hesitation: the family would make the trip. Eli enrolled in his first clinical trial, led by Dr. John Maris, an ALSF-funded researcher. The trip to Philadelphia was long and expensive; but the ALSF Travel for Care progr... Read More